Intellia Therapeutics (NTLA) has the highest short interest by a US stock in the Biotechnology Industry, with 39.8% of float sold short (44.361M shares).
| ASSET | SHARES SHORT | FLOAT | SHORT % OF FLOAT | SHORT RATIO |
|---|---|---|---|---|
Intellia Therapeutics (NTLA) | 44.3617M | 134.455M | 39.8% | 8.04 |
Beam Therapeutics (BEAM) | 26.0829M | 88.0742M | 38.92% | 13.75 |
AnaptysBio (ANAB) | 5.0502M | 20.3827M | 37.03% | 9.38 |
LENZ Therapeutics (LENZ) | 7.0697M | 22.2083M | 37.01% | 6.95 |
Replimune (REPL) | 24.6098M | 68.2174M | 36.13% | 10 |
C4 Therapeutics (CCCC) | 46.5806M | 102.7953M | 35.67% | 16.47 |
Capricor Therapeutics (CAPR) | 18.765M | 45.5479M | 35.63% | 5.24 |
Neurogene (NGNE) | 5.6859M | 11.9895M | 32.4% | 16.63 |
Ocugen (OCGN) | 107.672M | 334.4986M | 31.73% | 15.88 |
Abeona Therapeutics (ABEO) | 16.8798M | 34.927M | 31.69% | 15.58 |
Celcuity LLC (CELC) | 10.303M | 29.9115M | 31.59% | 5.62 |
Immunitybio (IBRX) | 126.0837M | 410.6794M | 31.14% | 8.32 |
Inhibrx Biosciences (INBX) | 3.3891M | 8.5787M | 30.74% | 12.06 |
Immuneering (IMRX) | 14.5957M | 49.2756M | 29.69% | 18.69 |
Tango Therapeutics (TNGX) | 48.2391M | 121.5213M | 28.83% | 10.59 |
Nuvation Bio (NUVB) | 61.9997M | 265.5433M | 28.82% | 10.79 |
Novavax (NVAX) | 46.3298M | 146.2755M | 28.26% | 5.48 |
Sellas Life Sciences (SLS) | 57.1262M | 203.0539M | 28.18% | 8.56 |
TG Therapeutics (TGTX) | 28.7656M | 133.4931M | 27.66% | 18.16 |
ARS Pharmaceuticals (SPRY) | 18.9906M | 49.1151M | 27.22% | 11.5 |
Compass Therapeutics (CMPX) | 40.7872M | 132.424M | 27.07% | 8.25 |
Summit Therapeutics (SMMT) | 42.263M | 154.2984M | 26.67% | 7.56 |
Q32 Bio (QTTB) | 5.5902M | 13.6653M | 26.52% | 5.74 |
Surrozen (SRZN) | 3.2349M | 12.3651M | 25.79% | 5.6 |
Biomea Fusion (BMEA) | 15.2121M | 67.5002M | 25.5% | 6.06 |
Historical short interest data is not available.